PR Newswire | Jun 1, 2021 09:03AM EDT

06/01 08:00 CDT

Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021 SAN DIEGO, June 1, 2021

SAN DIEGO, June 1, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Saundra Pelletier, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:

Date: Friday, June 4, 2021

Time: 10:30 a.m. ET (7:30 a.m. PT)

Webcast: https://wsw.com/webcast/jeff174/evfm/1851714

The presentation will be webcast live and archived for 30 days thereafter.

About Evofem BiosciencesEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company launched its first FDA-approved commercial product, Phexxi(r) (lactic acid, citric acid and potassium bitartrate), in the United States in September 2020. The Company is evaluating lead product candidate EVO100 for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeaeinfection in women in the ongoing Phase 3 clinical trial, 'EVOGUARD.' For more information, please visit evofem.com.

Phexxi(r) is a registered trademark of Evofem Biosciences, Inc.

Investor Relations ContactAmy RaskopfEvofem Biosciences, Inc.araskopf@evofem.comMobile: (917) 673-5775

View original content to download multimedia: http://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-jefferies-virtual-healthcare-conference-2021-301302444.html

SOURCE Evofem Biosciences, Inc.